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Abstract
 
Affinity maturation of the B cell response to antigen (Ag) takes place in the germinal centers
(GCs) of secondary follicles. Two sequential molecular mechanisms underpin this process.
First, the B cell repertoire is diversified through hypermutation of the immunoglobulin (Ig)
variable region genes. Second, mutant B cell clones with improved affinity for Ag are positively
selected by Ag and CD40 ligand (L). This selection step is contingent upon “priming” of GC B
cells for apoptosis. The molecular means by which B cell apoptosis is initiated and controled in
the GC remains unclear. Here, we show that GC B cell apoptosis is preceded by the rapid ac-
tivation of caspase-8 at the level of CD95 death-inducing signaling complex (DISC). We
found that GC B cells ex vivo display a preformed inactive DISC containing Fas-associated
death domain–containing protein (FADD), procaspase-8, and the long isoform of cellular
FADD-like IL-1
 
b
 
–converting enzyme-inhibitory protein (c-FLIP
 
L
 
) but not the CD95L. In
culture, c-FLIP
 
L
 
 is rapidly lost from the CD95 DISC unless GC B cells are exposed to the sur-
vival signal provided by CD40L. Our results suggest that (a) the death receptor signaling path-
 
way is involved in the affinity maturation of antibodies, and (b) c-FLIP
 
L
 
 plays an active role in
positive selection of B cells in the GC.
Key words: human • signal transduction • cell death • afﬁnity maturation • B lymphocytes
 
Introduction
 
Germinal centers (GCs)
 
1
 
 are specialized structures within
secondary lymphoid tissues in which B lymphocytes un-
dergo affinity maturation of their B cell receptors (BCRs).
This process develops in two steps that take place in dis-
tinct microanatomical compartments of the GC. First, the
Ab repertoire of Ag-activated B lymphocytes is diversified
in the GC dark zone through the random introduction of
point mutations in their Ig variable region genes. Second,
somatic mutants are tested in the GC light zone for their
capacity to efficiently take up Ag and present it to helper
T lymphocytes. B cells that have successfully passed this
selection test have two options. They can further differen-
tiate into memory cells or plasma cells and leave the GC,
or alternatively, they can return to the dark zone to un-
dergo another mutation/selection cycle (for reviews, see
references 1, ). Affinity maturation of the Ab response is
contingent on the enhanced propensity of GC B cells to
undergo apoptosis. This allows for (a) elimination of the
low affinity, irrelevant, and self-reactive B cell clones, and
(b) the selective rescue of the high affinity B cell clones
through the delivery of survival signals by Ag and CD40
ligand (CD40L; reference 3). It has been postulated that
during their clonal expansion and hypermutation phase in
the GC dark zone, B cells are protected from death by se-
creted or cell-bound antiapoptotic factors provided by the
follicular dendritic cells (FDCs; references 4, 5).
In vitro, isolated GC B cells spontaneously and rapidly
undergo apoptosis (3). It has been proposed that they are
“primed” to cell death because the equilibrium between
the negative and positive apoptosis regulators in these cells
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Abbreviations used in this paper:
 
 BCR, B cell receptor; c-FLIP, cellular
FLICE-inhibitory protein; c-FLIP
 
L
 
, long isoform of c-FLIP; c-FLIP
 
S
 
,
short isoform of c-FLIP; 
 
Dc
 
m, mitochondrial transmembrane potential
 
;
 
DD, death domain; DISC, death-inducing signaling complex; FADD,
Fas-associated death domain–containing protein; fmk, fluoromethylke-
tone; FLICE, FADD-like IL-1
 
b
 
–converting enzyme; FDC, follicular
dendritic cell; GC, germinal center; HRP, horseradish peroxidase; L,
ligand; PS, phosphatidylserine; RT, reverse transcription. 
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is displaced in favor of proapoptotic molecules such as Bax,
p53, or c-myc (6). It is generally admitted that initiation of
the apoptotic cascade in cultured GC B cells is consecutive
to their removal from their supportive stromal microenvi-
ronment and from the source of Ag and T cell help. There-
fore, GC B cell apoptosis has often been assimilated to a
form of death promoted by trophic factor deprivation. Sig-
nificant progress has been made in understanding the bio-
chemical mechanisms that control the execution of the ap-
optotic program in GC B cells. It has been documented
that both endonucleases (7) and cysteine proteases, includ-
ing both caspases and cathepsin (5), are required for GC B
cell apoptosis in vitro. As far as caspases are concerned, al-
though they intervene in the execution of most apoptotic
pathways, some, such as caspase-8 or -10, are more specifi-
cally involved in initiating transduction of the signal deliv-
ered by the so-called “death receptors” (8). One of the best
characterized members of this proapoptotic receptor family
is CD95 (Fas/APO-1). In the mature B cell compartment,
the strongest expression of CD95 is found on GC B cells
(9). Clustering of CD95 at the cell membrane induces re-
cruitment of the Fas-associated death domain–containing
protein (FADD) to the trimerized intracellular death do-
main (DD) of the receptor (10, 11). FADD in turn recruits
the proenzymatic form of caspase-8/FADD-like IL-1
 
b
 
–
converting enzyme (FLICE; references 12–14), thus lead-
ing to the formation of a multimolecular signaling platform
named death-inducing signaling complex (DISC; reference
15). After the formation of the DISC, caspase-8 is activated
by autoproteolytical cleavage and initiates a cascade of
caspases (16). One of the most proximal regulators of the
CD95-induced death program is FLICE-inhibitory protein
(FLIP). FLIP was first identified as a virus-encoded apopto-
sis-inhibitory protein, but its cellular homologue (c-FLIP)
also has the capacity to interfere with DISC formation (for
a review, see reference 17). Alternative splicing generates
two isoforms of c-FLIP: a long form (c-FLIP
 
L
 
) which con-
tains a caspase-like domain but is devoid of caspase catalytic
activity, and a short form (c-FLIP
 
S
 
) lacking the caspase-like
domain.
In this study, we report that human GC B cell apoptosis
relies on caspase-8 but not on caspase-9 activation. Our
data show that caspase-8 is cleaved at the level of the CD95
DISC within minutes when GC B cells are cultured in the
absence of exogenous stimuli. Immunoprecipitation of
CD95 or FADD in freshly isolated GC B cells revealed that
they display a preformed CD95 DISC that contains FADD,
the zymogen form of caspase-8 and c-FLIP
 
L
 
, but not the
CD95L. Since GC B cells express neither the transcript nor
the protein for the CD95L, our results suggest that CD95
self-aggregates on these cells. GC B cells rapidly lose
c-FLIP
 
L
 
 expression as they undergo apoptosis in vitro. Fur-
thermore, c-FLIP
 
L
 
 is no longer detected in the DISC of
apoptotic cells while FADD and caspase-8 are still con-
nected to CD95. Exposure of cultured GC B cells to the
survival signal provided by CD40L maintains expression of
c-FLIP
 
L
 
 and its association with the CD95 DISC. Alto-
gether, our findings suggest that (a) death receptors such as
CD95 are involved in the committment of GC B cells to
apoptosis, and (b) c-FLIP
 
L
 
 plays an active role in positive
selection of high affinity B cell mutants during the GC re-
action. The implications of these findings on the molecular
mechanisms underlying the affinity maturation process are
discussed.
 
Materials and Methods
 
Reagents and Abs. 
 
The trimeric human CD40L–leucine zip-
per fusion protein was provided by Dr. R. Armitage (Immunex,
Seattle, WA) and was used at 500 ng/ml throughout the study.
Rabbit anti–human Ig Abs coupled to polyacrylamide beads were
purchased from Irvine Scientific and used at a final dilution of
1:600. Four different anti-CD95 Abs were used. The agonistic
mAb 7C11 (IgM) and the antagonistic mAb ZB4 (IgG1) were
used for biological assays and purchased from Immunotech. The
agonistic anti–APO-1 mAb (18) was used for immunoprecipita-
tion of the CD95 DISC. A rabbit polyclonal anti-CD95 Ab
(Santa Cruz Biotechnology, Inc.) was used to reveal CD95 in the
immunoprecipitates. Purified mouse myeloma proteins used as
isotypic controls for the 7C11 (IgM) and anti–APO-1 (IgG3k)
mAbs were obtained from Sigma-Aldrich. mAbs 7C11 and anti–
APO-1 were used at 200 ng/ml and 3 
 
m
 
g/ml, respectively. mAb
ZB4 was used at 1 
 
m
 
g/ml. The anti-FADD mAb was purchased
from Transduction Laboratories and was used at 10 
 
m
 
g/ml for
immunoprecipitation studies. The anti-CD95L mAb G247-4 was
purchased from BD PharMingen and used at a final concentration
of 1 
 
m
 
g/ml. The C15 mAb recognizing the p18 subunit of
caspase-8 and the anti–c-FLIP mAb NF6 have been described
previously (19, 20). The anti–
 
b
 
-actin mAb was purchased from
Sigma-Aldrich. Horseradish peroxidase (HRP)-conjugated sheep
anti–mouse Abs (Amersham Pharmacia Biotech) were used for
the development of the immunoblots performed on cell lysates
with anti–caspase-8, c-FLIP, and FADD mAbs. For DISC analy-
sis by Western blot analysis, isotype-specific HRP-conjugated
secondary Abs (Southern Biotechnologies Associates, Inc.) were
used: goat anti–mouse IgG1 (for the c-FLIP and FADD mAbs)
and goat anti–mouse IgG2b for the anti–caspase-8 mAb. HRP-
conjugated donkey anti–rabbit Abs were used for the Western
blot analysis of CD95 in the immunoprecipitates. The broad
range caspase inhibitor z-VAD-fluoromethylketone (fmk), the
caspase-8–specific inhibitor z-IETD-fmk, the caspase-9–specific
inhibitor z-LEHD-fmk, and the control peptide z-FA-fmk were
purchased from Bachem and used at the concentrations indicated
in the text.
 
Cells. 
 
Purified tonsillar B cells were isolated as described
previously (21). GC and memory B cells were both isolated from
the IgD
 
2
 
 population by negative selection carried out with anti-
CD44 and anti-CD38 mAbs, respectively, as described previously
(9). A modified version of the protocol originally described by
Feuillard et al. (22) was used to isolate highly enriched virgin B
cells. In brief, GC and memory B cells were depleted after two
successive rounds of rosetting performed with sheep red blood
cells coated with anti-CD38 and anti-CD80 mAbs, respectively.
The purity of the negatively selected virgin B cell population
ranged from 70 to 85% due to the heterogeneous distribution of
CD80 on memory B cells. The human T leukemia cell line H9 in
which activation-induced cell death can be induced by CD3 trig-
gering was provided by Dr. Klaus-Michael Debatin (University
Children’s Hospital, Ulm, Germany). H9 cells stimulated for 6 h
with 10 
 
m
 
g/ml of the anti-CD3 mAb OKT3 were used as a pos- 
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itive control for the revelation of CD95-bound CD95L in immu-
noprecipitation studies.
 
Cultures. 
 
All cell cultures were made in RPMI 1640 supple-
mented with 10% selected heat-inactivated FCS, 2 mM 
 
L
 
-glu-
tamine, 100 U/ml penicillin, 100 
 
m
 
M/ml streptomycin, and 2%
Hepes (all from Life Technologies). GC B cells were seeded at a
density of 5
 
 3 
 
10
 
6
 
 cells/well in 12-well plates in the presence or
absence of (a) the anti-CD95 mAb 7C11 or its isotypic control,
(b) soluble trimeric CD40L, and (c) immobilized anti-Ig Abs, for
the times indicated in the text. To prepare CD95-sensitive B
blasts, virgin B cells were seeded at the density of 10
 
7
 
 cells in
6-well plates and stimulated for 48 h with CD40L. For secondary
cultures, viable B blasts recovered by density gradient centrifuga-
tion were seeded at 5
 
 3 
 
10
 
6
 
 cells/well in 12-well plates in the
presence of the anti-CD95 mAb 7C11 or its isotypic control.
 
Western Blot Analysis and Immunoprecipitation. 
 
For Western
blot analysis, cells (5 
 
3 
 
10
 
6
 
/sample) were washed twice with cold
PBS, resuspended in 100 
 
m
 
l of lysis buffer (10 mM Tris, pH 7.6,
150 mM NaCl, 1% Triton X-100, 10 mM EDTA) supplemented
with a protease inhibitor cocktail (Boehringer), and incubated for
15 min at 4
 
8
 
C. The cell-free supernatants were recovered by cen-
trifugation of the suspension at 10,000 
 
g
 
 for 15 min at 4
 
8
 
C. The
protein concentration of the extracts was determined by the
Lowry method (Bio-Rad Laboratories). For each sample, 30 
 
m
 
g
of protein was loaded on the gel, then separated by 12% SDS-
PAGE, and transferred to a Hybond nitrocellulose membrane
(Amersham Pharmacia Biotech). After transfer, the immunoblots
were blocked by incubating with 5% nonfat dry milk in Tris-
buffered saline and 0.1% Tween 20. Next, the blots were probed
overnight with the appropriate dilution of the primary Abs (anti–
caspase-8, c-FLIP, FADD, or 
 
b
 
-actin) at 4
 
8
 
C and revealed with
an HRP-conjugated sheep anti–mouse Ab (Amersham Pharmacia
Biotech) for 1 h at room temperature. After washing, the blots
were developed using the ECL chemiluminescence method
(Pierce Chemical Co.) according to the manufacturer’s protocol.
Immunoprecipitation of the CD95 DISC was carried out as
described previously (15). In brief, 10
 
7
 
 freshly isolated or cultured
GC B cells were incubated in complete medium at 37
 
8
 
C for dif-
ferent time intervals and lysed in lysis buffer (30 mM Tris-HCl,
150 mM NaCl, 1 mM PMSF, 1% Triton X-100, 10% glycerol,
and a protease inhibitor cocktail). The lysates were then supple-
mented with either 1 
 
m
 
g/ml anti–APO-1 mAb or 10 
 
m
 
g/ml
anti-FADD mAb. The CD95 or FADD-associated proteins were
then precipitated overnight at 4
 
8
 
C with protein A–Sepharose
(Sigma-Aldrich). The Sepharose beads were spun down, washed,
resuspended in SDS-gel sample buffer, and boiled at 95
 
8
 
C for 3
min. Immunoprecipitates were separated by 12% SDS-PAGE
and immunoblotted with anti-CD95, FADD, caspase-8, and
c-FLIP Abs.
 
Assays for Apoptosis. 
 
Quantitation of apoptotic cells was
made with (a) the 3,3
 
9
 
-dihexyloxacarbocyanine iodide (DiOC6)
fluorochrome (Molecular Probes), which reveals disruption of
the mitochondrial transmembrane potential (
 
Dc
 
m). In this assay,
apoptotic cells are identified by their decreased 
 
Dc
 
m (DiOC6
 
low
 
).
(b) Biotinylated annexin V (Boehringer) which detects the trans-
location of phosphatidylserine (PS) from the inner side to the
outer leaflet of the plasma membrane on apoptotic cells. Staining
was revealed with FITC-conjugated avidin (Immunotech) used
at 2.5 
 
m
 
g/ml. Immunofluorescence staining were analyzed on a
FACScan™ flow cytometer using the Lysis II software (Becton
Dickinson). (c) A PE-conjugated rabbit Ab specifically recogniz-
ing the active cleavage product of caspase-3 (BD PharMingen).
This Ab was used at the final concentration of 1 
 
m
 
g/ml.
 
Cytopreparations and May-Grünwald Giemsa Coloration. 
 
GC B
cells were resuspended at 4
 
 3 
 
10
 
6
 
 cells/ml in complete medium.
50 
 
m
 
l of this cell suspension was added in a cytocentrifuge cham-
ber and centrifuged at 350 rpm for 4 min with low break. The
slides were left to air dry before being fixed with methanol for 5
min at room temperature. The cytospins were incubated with a
2:3 dilution of May-Grünwald (BioLyon) solution prepared in
methanol for 5 min, washed in distilled water, then incubated
with a 1:9 dilution of Giemsa (RAL Products) prepared in dis-
tilled water for 10 min. The cytospins were then washed under
running water, air dried, and mounted.
 
Reverse Transcription PCR. 
 
Isolation of total RNA was per-
formed essentially as described by Chomczynski and Sacchi (23).
For reverse transcription (RT), 1 
 
m
 
g of RNA was converted into
single-stranded DNA by a standard 20-
 
m
 
l RT reaction using
random primers P(dN)6 (Boehringer) and Superscript™ kit
(RNAseH-MMLV reverse transcriptase; GIBCO BRL), accord-
ing to the manufacturer’s instructions. 1/10 of the total cDNA
product was amplified in a 50-
 
m
 
l reaction mixture using 1 
 
m
 
M
each of sense and antisense primers, and 1.25 U of Taq poly-
merase (PerkinElmer/Cetus). Expression of the 
 
b
 
-actin mRNA
was used as a control for RNA integrity and equal gel loading.
The amplification primers for CD95L and 
 
b
 
-actin were as
follows: CD95L, 5
 
9
 
-TAAAACCGTTTGCTGGGGC-3
 
9
 
 and
5
 
9
 
-CTCAGCTCCTTTTTTTCAGGCG-3
 
9
 
; and 
 
b
 
-actin, 5
 
9
 
-
GGGTCAGAAGGATTCCTATG-3
 
9
 
 and 5
 
9
 
-GGTCTCAAA-
CATGATCTGGG-3
 
9
 
. PCR products were run on a 1.5% aga-
rose gel, stained with ethidium bromide, and visualized by ultra-
violet illumination.
 
Results
 
Developmental Regulation of the Expression of Active Cas-
pase-8 and c-FLIP
 
L
 
 in the Mature B Cell Compartment. 
 
We
have previously documented that expression of CD95 is
modulated during the Ag-dependent B cell maturation
process (9). Here, we have first examined whether expres-
sion of the cytoplasmic components of the death receptor
signaling machinery could also be subjected to develop-
mental regulation in the mature B cell compartment. For
this purpose, Western blot analysis of FADD, caspase-8,
and c-FLIP was carried out in lysates of freshly isolated vir-
gin, GC, and memory B cells. As shown in Fig. 1, both
FADD and the zymogen form of caspase-8 are constitu-
Figure 1. Constitutive expres-
sion of FADD, caspase-8, and
c-FLIP in tonsillar B cell subsets.
Equal amounts (corresponding to
30 mg of proteins) of whole cell
extracts prepared from freshly
isolated virgin, GC, and mem-
ory B cells were loaded and sepa-
rated on 12% SDS-PAGE. After
transfer onto a nitrocellulose
membrane, the blots were first
probed with the anti–caspase-8
mAb, then stripped, and succes-
sively reblotted with the anti-
FADD, anti–c-FLIP, and b-actin
Abs. The proenzymatic form
(55 kD) and the active enzymatic form (18 kD) of caspase-8 are indicated
(arrowheads). Representative of three separate experiments. 
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tively expressed at equivalent levels in all three B cell sub-
sets. The 18-kD active cleavage product of caspase-8 was
only detected in memory B cells, suggesting a certain de-
gree of ongoing activation of this caspase in the memory
population in vivo. Expression of c-FLIP
 
L
 
 was marginal in
virgin and memory B cells but was significantly higher in
GC B cells. c-FLIP
 
S
 
 was absent from all the extracts.
Therefore, constitutive expression of c-FLIP
 
L
 
 or active
caspase-8 in the mature B cell compartment is restricted to
GC B cells and memory B cells, respectively.
 
Spontaneous Apoptosis of GC B Cells In Vitro Is Associated
with the Activation of Caspase-8. 
 
It is well documented
that isolated tonsillar GC B cells are committed to die un-
less they receive the appropriate contact-dependent rescue
signals from FDCs (4) or CD40L-expressing T cells (3). To
investigate the molecular mechanism underlying the in-
creased susceptibility of GC B cells to spontaneous apopto-
sis in vitro, we first examined whether caspases are in-
volved in this process. Three peptidic caspase inhibitors
were thus tested for their ability to prevent death of GC B
cells in culture: the broad range inhibitor z-VAD-fmk; the
caspase-8-specific inhibitor z-IETD-fmk; and the caspase-
9–specific inhibitor z-LEHD-fmk. To exclude the possible
contribution of the fmk chemical group to the observed ef-
fects, the cathepsin B inhibitor z-FA-fmk was used as a
negative control in these experiments. Freshly isolated GC
B cells were cultured for 24 h with or without serial dilu-
tions (ranging from 12.5 to 200 
 
m
 
M) of the four fmk pep-
tides mentioned above and processed for labeling of apop-
totic cells with biotinylated annexin V. As shown in Fig. 2,
both z-VAD-fmk and z-IETD-fmk rescue GC B cells from
apoptosis in a dose-dependent fashion. 80–90% of the cells
are still viable after 24 h of culture with 200 
 
m
 
M z-VAD or
Figure 2. Effect of caspase inhibitors on the spontaneous apoptosis of
GC B cells. Freshly isolated GC B cells were cultured for 24 h in the
presence or absence of the indicated concentrations of the caspase inhibi-
tors z-VAD-fmk (j), z-IETD-fmk (h), z-LEHD-fmk (s), or the con-
trol peptide z-FA-fmk (d). PS exposure was estimated by annexin V
binding. Data are presented as means of the percent viable cells (Ann. V2)
calculated from duplicate determinations. The difference between dupli-
cate measurements never exceeded 10% of the mean values. Representa-
tive of three experiments.
Figure 3. Morphology of GC B cells cultured with caspase inhibitors.
Freshly isolated GC B cells were cultured for 4 h in complete medium (CM)
supplemented or not with a 200 mM concentration of the caspase inhibitors
z-VAD-fmk, z-IETD-fmk, z-LEHD-fmk, or the control peptide z-FA-fmk.
The morphology of the cells was estimated by May-Grünwald Giemsa staining.
Original magnification: 3100. Representative of three experiments. 
451
 
Hennino et al.
 
z-IETD while the viability in control cultures drops below
10%. In contrast, the caspase-9 inhibitor z-LEHD-fmk ex-
erted only a marginal antiapoptotic effect on GC B cells,
and the control peptide z-FA-fmk failed to promote any
survival of GC B cells. This finding shows that spontaneous
apoptosis of GC B cells is a caspase-dependent process
which relies on the activation of caspase-8 but not of
caspase-9. To further document the differential implication
of caspase-8 and caspase-9 in apoptosis of GC B cells in
vitro, we examined the morphology of GC B cells after 4 h
of culture in the presence or absence of the four fmk pep-
tides. As illustrated by Fig. 3, many apoptotic figures, char-
acterized by nuclear condensation and fragmentation, are
seen in cultures carried out in complete medium, or in me-
dium to which the z-FA-fmk or z-LEHD-fmk peptides
were added. By contrast, most GC B cells cultured with
z-VAD-fmk or z-IETD-fmk show a normal healthy mor-
phology with a big nonfragmented nucleus.
Owing to the antiapoptotic effect exerted by the
caspase-8–inhibitory peptide z-IETD-fmk on cultured GC
B cells, we next estimated by Western blot analysis whether
spontaneous apoptosis of GC B cells in vitro was accompa-
nied by the cleavage of caspase-8. We had found previously
that CD40L-activated virgin B blasts that express high lev-
els of CD95 are sensitive to CD95-mediated killing and ac-
tivate caspase-8 in response to CD95 ligation (24). There-
fore, both the density of CD95 expression and the
occurrence of caspase-8 cleavage were compared in freshly
isolated GC B cells and in CD40L-stimulated B blasts. For
this purpose, both cell types were cultured either with the
agonistic anti-CD95 mAb 7C11 or with its isotypic con-
trol. Cell lysates were prepared at different time points of
the culture and probed with the anti–caspase-8 and FADD
mAbs. Fig. 4 A shows that although both cell types homo-
geneously express CD95, its relative density of expression is
approximately seven times higher on virgin B blasts than
on GC B cells ex vivo. As illustrated in Fig. 4 B, caspase-8
is rapidly activated in cultured GC B cells without the need
for deliberate CD95 ligation. Its active p16/p18 cleavage
products appear in GC B cell lysates as early as 40 min after
the onset of the cultures, independently of the addition of
the agonistic anti-CD95 mAb. The spontaneous processing
of caspase-8 in GC B cells is not potentiated by in vitro li-
gation of CD95. In spite of their higher density of CD95,
no spontaneous activation of caspase-8 is observed in virgin
B blasts within the time frame of the experiment. This re-
sult is consistent with our previous finding that caspase-8
cleavage in virgin B blasts is not detectable until 4 h of
stimulation with an agonistic anti-CD95 Ab (24). Alto-
gether these findings suggest that apoptosis of GC B cells in
culture is associated with the rapid and spontaneous activa-
tion of caspase-8. This peculiarity is not related to the levels
of expression of CD95 on GC B cells, but rather appears as
an intrinsic feature of this maturational stage.
 
Caspase-8 Is Activated at the Level of the CD95 DISC in
GC B Cells. 
 
Two cell types, each preferentially using
one of two different CD95 signaling pathways, have been
identified (25). In type I cells, cleavage of caspase-8 occurs
 
at the level of the DISC within minutes of CD95 ligation,
before the loss of
 
Dc
 
m. In type II cells, DISC formation is
strongly reduced, and activation of caspase-8 is delayed and
mainly occurs downstream of the mitochondria, consecu-
tive to 
 
Dc
 
m disruption. Although mitochondria are per-
turbed in both cell types, only type II cells depend on the
proapoptotic function of the mitochondria to execute the
death program initiated by ligation of CD95. Two obser-
vations suggested that caspase-8 could be activated through
its association with a death receptor signaling complex in
GC B cells. First, the p16/p18 cleavage products of
caspase-8 are detectable very early after the onset of GC B
cell cultures. Second, the caspase-8 inhibitory peptide
z-IETD prevented not only
 
 
 
PS exposure but also the mito-
Figure 4. Spontaneous activation of caspase-8 in cultured GC B cells.
(A) Viable CD40L-induced virgin B blasts and freshly isolated GC B cells
were analyzed for their expression of CD95 by labeling with the anti–
APO-1 (IgG3) mAb followed by PE-conjugated goat anti–mouse IgG3
Abs. The fluorescence histogram of the CD95 staining (hatched) is super-
imposed on that corresponding to the isotype-matched negative control
Ab. The “relative” mean fluorencent intensity (MFI) corresponds to the
ratio between the MFI of the CD95 fluorescence histogram and the MFI
of the negative control. (B) Same cells as in A were cultured in the pres-
ence (1) or absence (2) of the agonistic anti-CD95 mAb 7C11. Cells
were recovered and lysed at the indicated periods of time and equal
amounts of whole cell extracts were separated on 12% SDS-PAGE. The
blots were successively probed with the anti–caspase-8 and with the anti-
FADD mAbs and revealed with the appropriate HRP conjugate. Repre-
sentative of three experiments. 
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chondrial alterations in cultured GC B cells (data not
shown). These findings led us to test the hypothesis that
caspase-8 could be activated by association with the CD95
DISC. For this purpose, the proteins associated with either
CD95 or FADD were immunoprecipitated in freshly iso-
lated GC B cells or in GC B cells cultured in complete me-
dium without exogenous stimuli for different lengths of
time. Both CD95 and FADD immunoprecipitates were
analyzed by Western blotting using monoclonal or poly-
clonal Abs directed against the components of the DISC
(CD95, FADD, and caspase-8) or against the natural antag-
onist of the death receptor signaling pathway c-FLIP. As il-
lustrated by Fig. 5 A, FADD, the proform of caspase-8, and
c-FLIPL are found in the CD95 immunoprecipitates ob-
tained from freshly isolated GC B cells. c-FLIPS was below
the threshold of detection in all experiments performed.
Upon culturing in complete medium, CD95 remains asso-
ciated with FADD and caspase-8 but there is already a
strong reduction of c-FLIPL expression in the CD95 im-
munoprecipitates at the earliest time point (10 min). From
30 min of culture onwards, c-FLIPL is no longer associated
with the CD95 DISC. Expression of c-FLIP in the FADD
immunoprecipitates could not be assessed because both the
anti-FADD and anti–c-FLIP mAbs are of the same isotype.
However, examination of the FADD immunoprecipitates
(Fig. 5 B) confirmed that FADD, CD95, and procaspase-8
are readily associated in GC B cells ex vivo. Altogether,
these results provide several pieces of information. First,
GC B cells contain a preformed CD95 DISC which in-
cludes FADD, the zymogen form of caspase-8, and the nat-
ural CD95 antagonist c-FLIPL. Second, caspase-8 is acti-
vated at the level of the CD95 DISC during spontaneous
GC B cell apoptosis. Third, c-FLIPL disappears from the
multimolecular CD95 signaling complex within minutes of
in vitro culturing.
Activation of CD95 in GC B Cells Occurs in a Ligand-inde-
pendent Fashion.  Next we examined whether clustering
of CD95 and the subsequent formation of a DISC in GC B
cells was consecutive to the binding of CD95L. It has been
demonstrated that upon prolonged stimulation through
Figure 5. Composition of the
CD95 DISC in freshly isolated
and cultured GC B cells. (A)
CD95 or (B) FADD was immu-
noprecipitated (IP) from 107
freshly isolated GC B cells or at
different times after setting the
same cells in culture in complete
medium as described in Materials
and Methods. The immunopre-
cipitates were washed, subjected
to 10% SDS PAGE, and succes-
sively probed with the anti–
caspase-8, FADD, CD95, and
c-FLIP Abs. Representative of
three experiments.
Figure 6. GC B cells do not produce CD95L. (A) RT and
PCR amplification of the CD95L and b-actin transcripts were
performed on RNA extracts from freshly isolated GC B cells
and from PBLs which had been successively stimulated for 72 h
with PHA (5 mg/ml) and 6 h with PMA (10 ng/ml) and
ionomycin (0.5 mg/ml) (act. PBL). (B–D) Freshly isolated GC
B cells were cultured in complete medium (CM) in the pres-
ence or absence of the antagonistic anti-CD95 mAb ZB4 (1
mg/ml). GC B cells were assessed after 1, 2, 3, and 4 h of cul-
ture for their mitochondrial transmembrane potential (B), ex-
ternalization of PS (C), and activation of caspase-3 (D) using a
PE-conjugated anti-active caspase-3 Ab. The results are ex-
pressed as means of the (B) percent viable cells, (C) annexin
V1 cells, and (D) cells with activated caspase-3, calculated
from duplicate determinations. The difference between dupli-
cate measurements never exceeded 10% of the mean values.
Representative of three distinct experiments.453 Hennino et al.
their Ag receptor, T cells can express and release CD95L
that promotes their autocrine suicide (26). Two types of
experiments were undertaken to test whether the aggrega-
tion of CD95 on isolated GC B cells was consecutive to
their endogenous production of CD95L. First, we exam-
ined by RT-PCR the expression of the CD95L transcript
in freshly isolated GC B cells. As shown in Fig. 6 A, the
CD95L message was not detectable in GC B cells, whereas
it was expressed by PHA-activated PBLs which had been
restimulated for 6 h with PMA and ionomycin. Second,
we estimated whether blockade of the CD95–CD95L in-
teraction by the antagonistic anti-CD95 mAb ZB4 could
prevent apoptosis of GC B cells cultured for 1, 2, 3, and 4 h
in the absence of exogenous stimuli. Data shown in Fig. 6,
B–D, indicate that mAb ZB4 failed to prevent the Dcm
drop, PS exposure, and activation of caspase-3 in cultured
GC B cells. This suggests that aggregation of CD95 on GC
B cells is not because of an autocrine production loop of
CD95L. To test the possible involvement of exogenous
CD95L in multimerization of CD95, we next examined
whether CD95 was physically bound to its ligand in GC B
cells. For this purpose, we determined whether CD95L
was part of the CD95 DISC in GC B cells. The proteins
associated with FADD were thus immunoprecipitated in
freshly isolated GC B cells and in the human leukemic T
cells H9 which had been treated for 6 h with an anti-CD3
mAb. The H9 cell line was chosen as a positive control
since ligation of the TCR–CD3 complex on these cells
promotes their apoptosis via the endogenous release of
CD95L and its subsequent binding to CD95 (27). As
shown in Fig. 7, both CD95 and CD95L are coprecipitated
with FADD in CD3-activated H9 cells. Two bands mi-
grating respectively as a 40/42-kD species and as a 26-kD
species are revealed by the anti-CD95L mAb in the H9 im-
munoprecipitates. These two bands are likely to represent
the membrane-bound and the soluble form of CD95L, re-
spectively. They were also found in OKT3-treated Jurkat
T cells (data not shown). In contrast, despite the fact that
CD95 was efficiently coprecipitated with FADD in GC B
cells, no signal was obtained with the anti-CD95L mAb in
these immunoprecipitates. In agreement with our observa-
tion that GC B cells lack the CD95L transcript, whole cell
lysates prepared from GC B cells were also negative for the
expression of the CD95L protein. Altogether, these data
suggest that CD95L is not responsible for oligomerization
of CD95 and formation of a DISC in GC B cells.
The CD40- and BCR-mediated Rescue of GC B Cells Is
Correlated with the Upregulation of c-FLIPL.  It has been
shown previously that engagement of CD40 or BCR pro-
tects GC B cells from spontaneous apoptosis in vitro and
promotes expression of the bcl-2 protein (28). This finding
supported the concept that reinduction of antiapoptotic
members of the bcl-2 family was instrumental in positive
selection of mutated B cell clones which express a high af-
finity BCR for the relevant Ag. Since we had found that
entry of a GC B cell into apoptosis is correlated with
downregulation of c-FLIPL, we next investigated whether
the antiapoptotic signals provided by surrogate Ag or
CD40L could prevent the loss of c-FLIPL in cultured GC
B cells. For this purpose, Western blot analysis of c-FLIPL,
FADD, and caspase-8 was carried out in lysates of GC B
cells cultured for 12 h in the presence or absence of either
trimeric CD40L or immobilized anti-Ig Abs. As expected,
CD40L and anti-Ig Abs inhibit both PS exposure and the
activation of caspase-3 in GC B cell cultures (data not
shown). As shown in Fig. 8 A, the p18 cleavage product of
caspase-8 was clearly detectable in cultures of GC B cells
carried out in complete medium, whereas expression of
c-FLIPL was lost. In contrast, the p18 form of active
caspase-8 was undetectable in both CD40L- and anti-Ig–
treated cells. Furthermore, inhibition of caspase-8 process-
ing promoted by ligation of CD40 or BCR was tightly
correlated with the upregulation of c-FLIPL. To further
document that c-FLIPL is instrumental in promoting sur-
vival in CD40L-treated cells, time course experiments
were carried out in which both PS exposure and expression
of c-FLIPL were simultaneously monitored in cultured GC
B cells stimulated or not with CD40L. As illustrated by Fig.
8 B, the antiapoptotic effect of CD40L on GC B cells, as
estimated by the reduction of the proportion of cells bind-
ing annexin V, was not detectable before 4 h of culture. In
contrast, reexpression of c-FLIPL revealed by Western blot
analysis (Fig. 8 C) was already found within 2 h of CD40L
stimulation and thus preceded the inhibition of PS expo-
sure promoted by CD40L. Altogether, these findings sug-
gest that c-FLIPL contributes to the survival signal provided
by surrogate Ag or CD40L.
CD40L Prevents Dissociation of c-FLIPL from the CD95
DISC.  To investigate whether rescue signals control as-
sociation of c-FLIPL with the CD95 DISC, we analyzed
the composition of the CD95 signaling complex in
CD40L-activated GC B cells. CD40L was preferred to sur-
rogate Ag for these experiments since it consistently pro-
vided a stronger survival signal to GC B cells than anti-Ig
Figure 7. CD95L is not responsible for oligomerization of CD95 in GC
B cells. FADD was immunoprecipitated (IP) from 107 freshly isolated GC
B cells or 107 H9 cells previously stimulated for 6 h with the anti-CD3
mAb OKT3 (left two lanes). The immunoprecipitates were washed, sub-
jected to 10% SDS-PAGE, and successively probed with the anti-CD95L
and anti-CD95 Abs. Whole cell lysates prepared from the same batch of
GC B cells were run on the same gel and probed with the anti-CD95 and
anti-CD95L Abs (right lane). Representative of three experiments.454 c-FLIP Regulates B Cell Apoptosis in the Germinal Center
Abs. Immunoprecipitations with anti-CD95 and anti-
FADD Abs were thus carried out on (a) freshly isolated GC
B cells, (b) GC B cells cultured for 30 min in complete me-
dium, and (c) GC B cells stimulated for 4 and 6 h by tri-
meric CD40L. As shown in Fig. 9 A, c-FLIPL is no longer
detectable in the CD95 DISC by 30 min of culture of GC
B cells in complete medium but reassociates with the
CD95 signaling complex after 6 h of CD40L stimulation.
By contrast, FADD and the proform of caspase-8 remain
within the DISC whatever the culture conditions. This
contention is supported by the results of both the CD95
and FADD (Fig. 9 B) immunoprecipitation experiments.
Altogether, this finding suggests that the CD40L-mediated
rescue of GC B cells is correlated with the persistance of
c-FLIPL within the CD95 DISC.
Discussion
In this study, we show that the “commitment” of GC B
cells to programmed cell death which underlies the affinity
maturation process of the Ab response, involves CD95.
Furthermore, our data indicate that the cytoplasmic death
receptor antagonist c-FLIPL contributes to the positive se-
lection of mutant B cell clones with high Ag-binding affin-
ity in the GC. The experimental evidence that supports
this conclusion is discussed below.
To begin with, our data suggest that spontaneous apop-
tosis of GC B cells in vitro presents striking similarities with
the CD95-induced death of type I cells. First, caspase-8
which is one of the most proximal transduction elements of
Figure 8. c-FLIPL is upregulated in CD40L- or anti-Ig–stimulated GC
B cells. (A) Freshly isolated GC B cells (0) were cultured for 12 h in com-
plete medium with (1) or without (2) soluble trimeric CD40L or im-
mobilized anti-Ig Abs. Cell lysates were separated on 10% SDS-PAGE
and analyzed sequentially by Western blot for expression of FADD,
caspase-8, and c-FLIP. (B and C) GC B cells were cultured for the indi-
cated periods of time with or without soluble trimeric CD40L and pro-
cessed for analysis of PS exposure (B) or for analysis of c-FLIP expression
by Western blot. CM, complete medium. (C) In B, results are expressed
as means of the percent apoptotic cells (annexin V1) calculated from du-
plicate determinations. The difference between duplicate measurements
never exceeded 10% of the mean values. The blot shown in C was sub-
jected to densitometry scanning analysis. The relative intensity of c-FLIPL
expression at each time point (indicated below the c-FLIP blot) was esti-
mated by the ratio between the intensity of the c-FLIPL and b-actin
bands. Representative of three separate experiments.
Figure 9. Composition of the CD95 DISC in CD40L-stimulated GC
B cells. (A) CD95 or (B) FADD was immunoprecipitated (IP) from 107
freshly isolated GC B cells (0), or from the same cells cultured in com-
plete medium (CM) in the absence (30 min) or the presence (4 and 6 h)
of trimeric CD40L. The immunoprecipitates were washed, separated on
10% SDS-PAGE, and analyzed sequentially by Western blot for expres-
sion of c-FLIP, caspase-8, FADD, and CD95. Representative of three ex-
periments.455 Hennino et al.
the apoptotic signal initiated by death receptors (12–14) is
proteolytically cleaved within minutes of in vitro culturing
to release its active p16/p18 products. Second, we directly
demonstrate by immunoprecipitation experiments con-
ducted both with anti-CD95 and anti-FADD Abs that pro-
caspase-8 is constitutively complexed with FADD and
CD95 in freshly isolated GC B cells. Third, blockade of
caspase-8 activity but not caspase-9 by specific inhibitory
peptides prevents spontaneous apoptosis of GC B cells in
culture. This suggests that formation of the multimolecular
complex Cytc/Apaf-1/procaspase-9 (also called apopto-
some) downstream of the mitochondria is not mandatory
for execution of the death program in GC B cells. On the
other hand, the crucial importance of the mitochondrial
death pathway in the GC reaction has been highlighted by
the observation that expression of a bcl-2 or a bcl-xL trans-
gene inhibits apoptosis in the GC (29) and impairs the pro-
cess of affinity maturation (30, 31). One explanation that
would reconcile our present observations with the latter re-
ports is that other mitochondrial apoptogenic proteins such
as AIF, whose release from the mitochondria is also pre-
vented by bcl-2 (32), collaborate with caspases to promote
GC B cell apoptosis. Alternatively, it is also possible that
the antiapoptotic members of the Bcl-2 family intervene at
later stages of the rescue process to secure the long-term
survival of the selected high affinity mutant B cell clones.
In support of this hypothesis is the observation that the
CD40-mediated rescue of GC B cells from apoptosis is ef-
fective hours before these cells reexpress significant levels of
the Bcl-2 protein (33). In this scenario, c-FLIPL would
promote rapid but transient protection while the later in-
duction of Bcl-2 or Bcl-xL would confer a durable apopto-
sis-resistant phenotype.
As opposed to the DISC formed upon in vitro ligation of
CD95 in sensitive activated peripheral T cells (20) or
CD40L-activated virgin B blasts (24), only the full-length
forms of caspase-8 and c-FLIPL are found within the CD95
DISC of freshly isolated GC B cells. Therefore, although
caspase-8 is connected to CD95 and FADD in such a
DISC, its autoproteolytic cleavage is prevented, thus ren-
dering this signaling complex nonfunctional. Several pieces
of evidence suggest that it is c-FLIPL that precludes activa-
tion of caspase-8 at the level of the CD95 DISC in GC B
cells. First, from all three B cell subsets examined, only
GC B cells constitutively express significant levels of the
c-FLIPL protein. Furthermore, appearance of the active
cleavage products of caspase-8 in cultured GC B cells is in-
versely correlated with the expression of c-FLIPL. Alto-
gether, these observations are compatible with the hypoth-
esis that execution of the cell death program in GC B cells
is prevented as long as c-FLIPL remains associated with the
CD95 DISC. The molecular mechanism whereby c-FLIPL
exerts its antiapoptotic function is not entirely clear. How-
ever, in most CD95-resistant cells, c-FLIP forms stable
complexes with CD95, FADD, and caspase-8 (20, 34).
Our present findings are in line with these observations
and support the notion that association of caspase-8 and
c-FLIPL within the same DISC blocks the autoproteolytic
cleavage of caspase-8.
Removal of GC B cells from their microenvironment
results in the rapid exclusion of c-FLIPL from the CD95
DISC since it is no longer coprecipitated with CD95 after
only 30 min of in vitro culturing. As illustrated by the hy-
pothetical model depicted in Fig. 10, we postulate that
c-FLIPL expression in GC B cells should be maintained un-
der two circumstances. The first is when B cells have to be
Figure 10. Hypothetical model
for the role of c-FLIPL in affinity
maturation of the Ab response.
This model proposes that the
CD95 signaling pathway plays a
central role in the selection of the
B cell repertoire in the GC. Our
data are compatible with the hy-
pothesis that CD95 is oligomer-
ized in GC B cells and con-
stitutively connected with the
proximal elements of its signaling
pathway. Association of c-FLIPL
in the CD95 DISC prevents B
cells from undergoing apoptosis
while they expand and somati-
cally mutate in the dark zone of
the GC. The existence of a pre-
formed CD95 DISC in GC B
cells would allow for rapid elimi-
nation of unwanted B cells (low
affinity B cell mutants) when they
are selected on the basis of their
ability to capture Ag and present
it to T helper cells in the light zone of the GC. We postulate that non–Ag-derived signals (possibly provided by the FDCs) maintain the expression of
c-FLIPL during diversification of the B cell repertoire in the dark zone. These signals are no longer available as GC B cells move to the light zone where se-
lection occurs. After the loss of c-FLIPL expression, the CD95 DISC becomes operational and promotes cell death unless GC B cells are signaled through
their Ag receptor and cognate interaction with T helper cells.456 c-FLIP Regulates B Cell Apoptosis in the Germinal Center
protected from apoptosis while they expand and mutate
their Ig genes in the dark zone of the GC. T cell help is
minimal if present at all in this microanatomical compart-
ment of the GC. Furthermore, all mutated B cell clones
must be preserved at this stage, independently of the af-
finity of their BCR. Thus, we favor the hypothesis that
c-FLIPL expression in centroblasts of the dark zone is
maintained through non-Ag-dependent mechanisms. The
second is when B cell variants which the BCR displays an
improved affinity for the Ag which initiated the response
are positively selected by Ag and CD40L. We assume that,
to ensure selectivity of the rescue process, the Ag-indepen-
dent signals which promoted c-FLIPL expression in the
dark zone must no longer be available when positive selec-
tion occurs in the GC light zone. Therefore c-FLIPL in the
GC plays the role of a molecular switch turning the pre-
formed CD95 signaling complex on or off.
The conclusion that c-FLIPL behaves as an early media-
tor of the antiapoptotic signal delivered by CD40L is sup-
ported by our observation that reexpression of c-FLIPL
precedes by at least 2 h the restoration of the integrity of
the plasma membrane in CD40L-treated GC B cells. The
early loss of c-FLIPL reactivity in the cell lysates of cultured
GC B cells (Fig. 8 C) suggests that its disappearance from
the CD95 immunoprecipitates is not merely the conse-
quence of its dissociation from the DISC. It is not yet clear
how c-FLIPL expression can become extinct in GC B cells
but the rapidity of the phenomenon evokes the possibility
of a conformational change or degradation of the c-FLIPL
protein. At face value, our hypothesis that c-FLIPL initiates
the survival signal delivered by CD40L is difficult to recon-
cile with the kinetics of reexpression of c-FLIPL in
CD40L-activated B cells and of caspase-8 cleavage in un-
treated GC B cells. We show that caspase-8 is rapidly acti-
vated (within 40 min) in untreated GC B cell cultures
while c-FLIPL is hardly detectable before 2 h of CD40L
stimulation (that is, later than the first signs of caspase-8
cleavage). One possibility would be that completion of the
apoptotic program in GC B cells requires sustained activa-
tion of caspase-8. In other words, the amounts of active
caspase-8 produced before the CD40L-mediated reinduc-
tion of c-FLIPL may not be sufficient to irreversibly engage
GC B cells to die. Alternatively, it is also possible that rela-
tively low levels of c-FLIPL expression (which would fall
below the thresholds of detection of the Western blot anal-
ysis) are sufficient to block caspase-8 activation in GC B
cells. In any case, further experiments will be required to
nail down the precise function and mode of action of
c-FLIPL during GC B cell apoptosis.
Our finding that CD95L is neither endogenously pro-
duced by GC B cells nor associated with the CD95 DISC
suggests that oligomerization of CD95 in GC B cells occurs
in a ligand-independent fashion. Self-aggregation of death
receptors and subsequent activation of the apoptotic ma-
chinery are common when these molecules are overex-
pressed. This has been documented in particular for the
TNF-receptor 1/TNF-R1 (35). In fact, it has recently
been shown that several members of the TNF receptor
family including CD95 and TNF-R1 are constitutively ex-
pressed as oligomers rather than as monomers on the cell
surface (36, 37). These oligomerized death receptors could
be maintained in a silent state by cytoplasmic regulators. At
least, two distinct molecules have been described to fulfill
this function. The first is a protein called silencer of
death domain (SODD) which binds the DD of TNF-R1
and DR3/TNF-R–mediated apoptosis–mediating protein
(TRAMP) (38). The second, designated sentrin (39), can
associate with the DD of both TNF-R1 and CD95. Both
proteins prevent spontaneous transduction of the apoptotic
signal when they are bound to the DD of these receptors.
The release of such a silencer molecule from CD95 as B
cells penetrate the follicles to participate in the GC reaction
could allow for recruitment and association of the cytoplas-
mic components of the DISC.
The role of CD95 in the process of affinity maturation
that we postulate in this study is in contradiction to the
study of Smith et al. showing that the selection of high af-
finity mutants in the GC is not affected in lpr mice immu-
nized with a T cell–dependent Ag (40). A scenario that
would be consistent both with our data and with the latter
study is that the CD95 deficiency is compensated for by
another death receptor in lpr mice. Because our immuno-
precipitation studies revealed that caspase-8 is associated
with FADD in GC B cells, DR3/TRAMP (41), TNF-R1
(42), and the TNF-related apoptosis-inducing ligand
(TRAIL) receptors 1 and 2 (43, 44), which all rely on
FADD to transduce their death signal, stand as possible
candidates. Unfortunately, this question cannot be ad-
dressed in mice with targeted disruption of the FADD gene
in the lymphoid compartment since these animals lack ma-
ture B cells in the periphery (45). Finally, the regulation of
the B cell’s life and death in the GC is likely to be a multi-
factorial process. It has already been shown that FDCs can
interfere with distal steps of the GC cell death pathway by
silencing a nuclear endonuclease activity (7) and by neu-
tralizing a cathepsin activity (5). Our present findings indi-
cate that the microenvironment of the GC also regulates B
cell survival at a death receptor–proximal level by main-
taining the expression of antagonists such as c-FLIPL.
I dedicate this article to the memory of my father, Robert De-
france.
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